DNAJB1-PRKACA is specific for fibrolamellar carcinoma-Reference-Cited by-同舟云学术

DNAJB1-PRKACA is specific for fibrolamellar carcinoma

Published:2015-02-20 Issue:6 Volume:28 Page:822-829
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Graham Rondell P,Jin Long,Knutson Darlene L,Kloft-Nelson Sara M,Greipp Patricia T,Waldburger Nina,Roessler Stephanie,Longerich Thomas,Roberts Lewis R,Oliveira Andre M,Halling Kevin C,Schirmacher Peter,Torbenson Michael S

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol20154.pdf

Reference26 articles.

1. Craig JR, Peters RL, Edmondson HA et al. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980;46:372–379.

2. Folpe AL, Weiss SW . Ossifying fibromyxoid tumor of soft parts: a clinicopathologic study of 70 cases with emphasis on atypical and malignant variants. Am J Surg Pathol 2003;27:421–431.

3. Honeyman JN, Simon EP, Robine N et al. Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. Science 2014;343:1010–1014.

4. El-Serag HB, Davila JA . Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology 2004;39:798–803.

5. Vivekanandan P, Micchelli ST, Torbenson M . Anterior gradient-2 is overexpressed by fibrolamellar carcinomas. Hum Pathol 2009;40:293–299.

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organoid as a promising tool for primary liver cancer research: a comprehensive review;Cell & Bioscience;2024-08-27

2. Distinct phases of cellular signaling revealed by time-resolved protein synthesis;Nature Chemical Biology;2024-07-08

3. FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion;Frontiers in Oncology;2024-03-28

4. Fibrolamellar Hepatocellular Carcinoma (FLHCC) in a Young Patient Presenting With Nausea and Vomiting After a Greasy Meal;Cureus;2024-03-09

5. Recent advances in the investigation of fusion RNAs and their role in molecular pathology of cancer;The International Journal of Biochemistry & Cell Biology;2024-03